Form D · Biotechnology
Euthymics Bioscience, Inc.
Cambridge, MA · CIK 0001066833
Offering snapshot reported Jun 1, 2017 · SEC filing
- Reported sold
- $300K Offering amount: $500K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 23, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 1, 2017 | Initial | $300,000 | No comparison | 7 | SEC filing |
| Nov 27, 2012 | Initial | $3,000,000 | No comparison | 7 | SEC filing |
| May 30, 2012 | Amendment | $28,008,945 | $3,709,097vs Mar 16, 2012 | 7 | SEC filing |
| Mar 16, 2012 | Amendment | $24,299,848 | $1,927,197vs Mar 17, 2011 | 7 | SEC filing |
| Mar 17, 2011 | Amendment | $22,372,651 | $17,208,325vs Jul 29, 2010 | 7 | SEC filing |
| Jul 29, 2010 | Initial | $5,164,326 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-287854
Source: Form D, filed Jun 1, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Bailey | Director |
| Andrew Baker | Director |
| Timothy Barberich | Director |
| Douglas A. Branch | Executive |
| Franklin P. Bymaster | Executive |
| Joshua Funder | Director |
| Frank Gentile | Director |
| Anthony Mc Kinney | Director, Executive |
| Campbell Murray | Director |
| Daniel Omstead | Director |
| William Pappafotopoulos | Executive |
| Thomas A. Shea | Executive |
| Brigitte Smith | Director |
| Albert L. Sokol | Executive |
| Pierre Tran | Executive |
| Paul Weiss | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
43 Thorndike Street, Suite S1 3
Cambridge, MA, 02141
Cambridge, MA, 02141